 |
- About Reid
- Medical Services
- Support Services
- Patient & Visitor Info
- Foundation
- Make a Gift
- Mission Report
- I Am Thankful Campaign
- Board of Directors
- Jim Brower
- Denny Burns, Vice Chair
- Jackie Carberry
- Tom Cox
- Mary Davis
- Phil Dickman
- Debra Edelman
- Lee Elzemeyer, Secretary/Treasurer
- Jon Ford
- Earl Goble, Auxiliary President
- Gary Hemmelgarn
- Craig Kinyon, CEO
- Rev. Max Knight
- John McBride, Chair
- Reverend Dixie Miller
- Tim Miller
- Eleanor Oberle
- Linda Paust
- Bob Powell
- Lynn Sheets
- Alan Spears
- Ashton Veramallay
- Phyllis Wesler
- Donor Stories
- Foundation Events
- Benefitting the Future
- Contact Us
- What's New
- Careers
- Current Openings
- Physician Openings
- Apply Online
- Volunteering at Reid
- Life & Work at Reid
- School of Radiologic Technology
- Employee Benefits
- Find A Physician
 |
 |
 |
Clinical Trials
In an effort to obtain the best cancer treatment possible, clinical trials for new cancer treatments - drugs or chemotherapy, new approaches to surgery, radiation therapy or a combination of these treatments - are tested in cancer patients.
In 2005, Reid Hospital joined the Dayton Clinical Oncology Program (DCOP), a non-profit community health care organization comprised of primarily Southwest Ohio and Indiana hospitals as well as Wright State University. Funded by the National Cancer Institute and formulated to coordinate cancer research in this region, the goal of our clinical trials or studies are to prevent cancer, define more effective cancer treatments, reduce the recurrence of cancer, increase cancer patients' survival rate, improve symptom management and provide a better quality of life for all cancer patients.
All new cancer treatments must be tested on humans and must pass three separate phases before being approved by the Food and Drug Administration (FDA).
- Phase I: This clinical trial involves only a small number of people. The treatment is evaluated for safety, dose and effectiveness. If the results are good, the treatment moves on to Phase II.
- Phase II: This clinical trial tests a small amount of patients to see if the treatment works against a certain type of cancer. If it does, it moves on to Phase III.
- Phase III: This clinical trial involves hundreds and sometimes thousands of patients. It compares the standard or known treatment to the new treatment.
Each year, more than 25,000 individuals enroll in clinical trials. Most trials that patients join are Phase III trials.
To find out if you qualify for a clinical trial, please talk to your physician and discuss all treatment options available.
 |
|
||